Skip to main content

Table 3 Cardiovascular risk factors and aspirin use among examination subgroup free of disease

From: Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance

  N = 184
Age, median (IQR) 59.5 (51–67.5)
Male, n (%) 78 (42.4%)
White, non-hispanic, n (%) 161 (87.5%)
Black, non-hispanic, n (%) 8 (4.4%)
Hispanic, n (%) 15 (8.2%)
Community sample, n (%) 137 (74.5%)
Health facility sample, n (%) 47 (25.5%)
Weight, kg, median (IQR) 79.8 (66.7-92.1)
BMI, kg m2, median (IQR) 26.4 (23.6-30.7)
SBP, mmHg, median (IQR) 118 (111–123)
DBP, mmHg, median (IQR) 68 (61–75)
LDL, median (IQR) 105 (81–129)
HDL, median (IQR) 62 (47–74)
Triglycerides, median (IQR) 117 (84–171)
Current or recent (<1 yr) tobacco smoker, n (%) 16 (8.7%)
Told you have diabetes by health professional, n (%) 27 (14.8%)
Hgb A1C >6.5% or using an oral hypoglycemic medication, n (%) 24 (13.1%)
Ten-year CHD Risk <10%, n (%) 160 (87.0%)
Ten-year CHD Risk ≥10%, n (%) 24 (13.1%)
Routine aspirin use 66 (35.9%)
Risks and benefits of aspirin to prevent heart attack or stroke  
ever discussed with you 92 (50.0%)
Health problem that make aspirin or NSAIDs unsafe 21 (11.4%)